Source: Vaccine: x. Unidade: FM
Subjects: IMUNOGENICIDADE DA VACINA, DOENÇAS AUTOIMUNES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AIKAWA, Nadia Emi et al. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, v. 10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jvacx.2021.100131. Acesso em: 25 set. 2024.APA
Aikawa, N. E., Balbi, V. A., Borba Neto, E. F., Tonacio, A. C., Sallum, A. M. E., Campos, L. M. A., et al. (2022). Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases. Vaccine: x, 10. doi:10.1016/j.jvacx.2021.100131NLM
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131Vancouver
Aikawa NE, Balbi VA, Borba Neto EF, Tonacio AC, Sallum AME, Campos LMA, Sartori AMC, Antonangelo L, Silva CAA da, Bonfa ESD de O. Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases [Internet]. Vaccine: x. 2022 ; 10[citado 2024 set. 25 ] Available from: https://doi.org/10.1016/j.jvacx.2021.100131